- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Cellceutix Corp (C0C)
| Open: | 1.462 | Day's Range: | 1.462 - 1.462 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 1.500 | 52wk Range: | 1.022 - 1.915 | 1-Yr Rtn: | - |
Key Statistics for C0C
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 25 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 10/11/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for C0C
Company Profile & Key Executives for C0C
Cellceutix Corporation is a development-stage biopharmaceutical company. The Company's current portfolio of product candidates in pre-clinical development includes anti-cancer agents targeting multiple tumors, candidate targeting rheumatoid arthritis, candidate with potential for indications of osteo-arthritis/asthma, candidate being developed for autism.
| Leo EhrlichChairman/CEO/CFO | Krishna MenonPres/Chief Scientific Ofcr/Founder |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
C0C News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page